Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Antibody agonists trigger immune receptor signaling through local exclusion of receptor-type protein tyrosine phosphatases.
Immunity. 2024 Feb 13;57(2):256-270.e10. doi: 10.1016/j.immuni.2024.01.007.
Immunity. 2024.
PMID: 38354703
Free article.
Combination CD200R/PD-1 blockade in a humanised mouse model.
Fellermeyer M, Anzilotti C, Paluch C, Cornall RJ, Davis SJ, Gileadi U.
Fellermeyer M, et al. Among authors: paluch c.
Immunother Adv. 2023 Mar 30;3(1):ltad006. doi: 10.1093/immadv/ltad006. eCollection 2023.
Immunother Adv. 2023.
PMID: 37082107
Free PMC article.
Item in Clipboard
Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation.
Kennedy A, Waters E, Rowshanravan B, Hinze C, Williams C, Janman D, Fox TA, Booth C, Pesenacker AM, Halliday N, Soskic B, Kaur S, Qureshi OS, Morris EC, Ikemizu S, Paluch C, Huo J, Davis SJ, Boucrot E, Walker LSK, Sansom DM.
Kennedy A, et al. Among authors: paluch c.
Nat Immunol. 2022 Sep;23(9):1365-1378. doi: 10.1038/s41590-022-01289-w. Epub 2022 Aug 23.
Nat Immunol. 2022.
PMID: 35999394
Free PMC article.
Item in Clipboard
Immune Checkpoints as Therapeutic Targets in Autoimmunity.
Paluch C, Santos AM, Anzilotti C, Cornall RJ, Davis SJ.
Paluch C, et al.
Front Immunol. 2018 Oct 8;9:2306. doi: 10.3389/fimmu.2018.02306. eCollection 2018.
Front Immunol. 2018.
PMID: 30349540
Free PMC article.
Review.
Item in Clipboard
Galectin-3 acts as an angiogenic switch to induce tumor angiogenesis via Jagged-1/Notch activation.
Dos Santos SN, Sheldon H, Pereira JX, Paluch C, Bridges EM, El-Cheikh MC, Harris AL, Bernardes ES.
Dos Santos SN, et al. Among authors: paluch c.
Oncotarget. 2017 Jul 25;8(30):49484-49501. doi: 10.18632/oncotarget.17718.
Oncotarget. 2017.
PMID: 28533486
Free PMC article.
Item in Clipboard
Anti-CD3 treatment up-regulates programmed cell death protein-1 expression on activated effector T cells and severely impairs their inflammatory capacity.
Wallberg M, Recino A, Phillips J, Howie D, Vienne M, Paluch C, Azuma M, Wong FS, Waldmann H, Cooke A.
Wallberg M, et al. Among authors: paluch c.
Immunology. 2017 Jun;151(2):248-260. doi: 10.1111/imm.12729. Epub 2017 Mar 16.
Immunology. 2017.
PMID: 28211040
Free PMC article.
Item in Clipboard
Cite
Cite